Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Assets ratio high or low?
The EV/Assets ratio of 1.55x is 62% below its estimated 2-year average of 4.12x, near the low end of its estimated 2-year range (1.22x–13.92x).
As of 2026-10-06T16:16:37.718Z. 38.47% below its estimated 12-month average of 2.52x.
Calculation as of: 2026-10-06T16:16:37.718Z.
Quote observation: 2026-10-06T16:14:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 869772d5b15fe2f366f7470de3318cdd420f1d22994776f46b79eb6f67ec6a89
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
1.55x
EV/ASSETS RATIO AVG TTM
2.52x
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-38.47%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.56x
median of 666 covered companies
CURRENT VS SECTOR MEDIAN
-0.32%
vs the sector median at left
Eupraxia Pharmaceuticals Inc.
Market Cap
$266.78M
EV/Assets Ratio
1.55x
TTM Avg
2.52x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.51M
EV/Assets Ratio
1.44x
TTM Avg
1.38x
3Y Avg
1.64x
5Y Avg
1.30x
Market Cap
$267.70M
EV/Assets Ratio
0.33x
TTM Avg
0.22x
3Y Avg
0.27x
5Y Avg
0.51x
Market Cap
$268.35M
EV/Assets Ratio
0.79x
TTM Avg
3.29x
3Y Avg
2.29x
5Y Avg
1.83x
Market Cap
$263.44M
EV/Assets Ratio
0.70x
TTM Avg
2.10x
3Y Avg
1.88x
5Y Avg
1.88x
Market Cap
$261.58M
EV/Assets Ratio
1.07x
TTM Avg
1.56x
3Y Avg
1.69x
5Y Avg
4.96x
Market Cap
$275.17M
EV/Assets Ratio
0.18x
TTM Avg
0.97x
3Y Avg
2.17x
5Y Avg
2.23x
Market Cap
$257.56M
EV/Assets Ratio
1.32x
TTM Avg
0.92x
3Y Avg
0.95x
5Y Avg
0.96x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eupraxia Pharmaceuticals Inc. (EPRX) | $266.78M | 1.55x | 2.52x | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $266.51M | 1.44x | 1.38x | 1.64x | 1.30x |
| OraSure Technologies, Inc. (OSUR)vs › | $267.70M | 0.33x | 0.22x | 0.27x | 0.51x |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $268.35M | 0.79x | 3.29x | 2.29x | 1.83x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $263.44M | 0.70x | 2.10x | 1.88x | 1.88x |
| Palisade Bio, Inc. (PALI)vs › | $261.58M | 1.07x | 1.56x | 1.69x | 4.96x |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $275.17M | 0.18x | 0.97x | 2.17x | 2.23x |
| Scribe Therapeutics Inc. (SCTX)vs › | $274.77M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.56M | 1.32x | 0.92x | 0.95x | 0.96x |
| Fate Therapeutics, Inc. (FATE)vs › | $276.83M | 1.23x | 0.81x | 0.73x | 1.46x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-10-05 | 3.31x |
| 2026-10-02 | 3.07x |
| 2026-10-01 | 3.35x |
| 2026-09-30 | 3.95x |
| 2026-09-29 | 3.58x |
| 2026-09-28 | 3.53x |
| 2026-09-25 | 3.44x |
| 2026-09-24 | 3.51x |
| 2026-09-23 | 3.50x |
| 2026-09-22 | 3.71x |
| 2026-09-21 | 3.74x |
| 2026-09-18 | 3.71x |
| 2026-09-17 | 3.61x |
| 2026-09-16 | 3.48x |
| 2026-09-15 | 3.48x |
| 2026-09-14 | 3.47x |
| 2026-09-11 | 3.63x |
| 2026-09-10 | 3.44x |
| 2026-09-09 | 3.47x |
| 2026-09-08 | 3.55x |
| 2026-09-04 | 3.62x |
| 2026-09-03 | 3.20x |
| 2026-09-02 | 3.17x |
| 2026-09-01 | 2.65x |
| 2026-08-31 | 2.70x |
| 2026-08-28 | 2.81x |
| 2026-08-27 | 3.13x |
| 2026-08-26 | 3.16x |
| 2026-08-25 | 3.16x |
| 2026-08-24 | 3.09x |
| 2026-08-21 | 2.83x |
| 2026-08-20 | 2.84x |
| 2026-08-19 | 2.96x |
| 2026-08-18 | 2.89x |
| 2026-08-17 | 2.87x |
| 2026-08-14 | 2.83x |
| 2026-08-13 | 2.80x |
| 2026-08-12 | 2.71x |
| 2026-08-11 | 2.23x |
| 2026-08-10 | 2.21x |
| 2026-08-07 | 2.25x |
| 2026-08-06 | 2.21x |
| 2026-08-05 | 2.14x |
| 2026-08-04 | 2.16x |
| 2026-08-03 | 2.15x |
| 2026-07-31 | 2.11x |
| 2026-07-30 | 2.17x |
| 2026-07-29 | 1.94x |
| 2026-07-28 | 1.99x |
| 2026-07-27 | 2.02x |
| 2026-07-24 | 1.88x |
| 2026-07-23 | 2.07x |
| 2026-07-22 | 2.12x |
| 2026-07-21 | 2.10x |
| 2026-07-20 | 2.05x |
| 2026-07-17 | 2.18x |
| 2026-07-16 | 2.01x |
| 2026-07-15 | 2.16x |
| 2026-07-14 | 2.09x |
| 2026-07-13 | 2.12x |
| 2026-07-10 | 2.22x |
| 2026-07-09 | 2.31x |
| 2026-07-08 | 2.31x |
| 2026-07-07 | 2.21x |
| 2026-07-06 | 2.16x |
| 2026-07-02 | 2.22x |
| 2026-07-01 | 2.23x |
| 2026-06-30 | 2.19x |
| 2026-06-29 | 2.18x |
| 2026-06-26 | 2.19x |
| 2026-06-25 | 2.11x |
| 2026-06-24 | 2.05x |
| 2026-06-23 | 2.10x |
| 2026-06-22 | 2.20x |
| 2026-06-18 | 2.14x |
| 2026-06-17 | 2.07x |
| 2026-06-16 | 1.96x |
| 2026-06-15 | 2.04x |
| 2026-06-12 | 1.97x |
| 2026-06-11 | 1.96x |
| 2026-06-10 | 1.92x |
| 2026-06-09 | 1.94x |
| 2026-06-08 | 1.95x |
| 2026-06-05 | 1.93x |
| 2026-06-04 | 2.13x |
| 2026-06-03 | 2.08x |
| 2026-06-02 | 2.21x |
| 2026-06-01 | 2.29x |
| 2026-05-29 | 2.38x |
| 2026-05-28 | 2.49x |
| 2026-05-27 | 2.41x |
| 2026-05-26 | 2.55x |
| 2026-05-22 | 2.38x |
| 2026-05-21 | 2.32x |
| 2026-05-20 | 2.10x |
| 2026-05-19 | 2.07x |
| 2026-05-18 | 2.22x |
| 2026-05-15 | 2.31x |
| 2026-05-14 | 2.40x |
| 2026-05-13 | 2.56x |
| 2026-05-12 | 3.65x |
| 2026-05-11 | 3.54x |
| 2026-05-08 | 3.56x |
| 2026-05-07 | 3.57x |
| 2026-05-06 | 3.64x |
| 2026-05-05 | 3.45x |
| 2026-05-04 | 3.54x |
| 2026-05-01 | 3.82x |
| 2026-04-30 | 3.77x |
| 2026-04-29 | 3.49x |
| 2026-04-28 | 3.35x |
| 2026-04-27 | 3.41x |
| 2026-04-24 | 3.38x |
| 2026-04-23 | 3.44x |
| 2026-04-22 | 3.32x |
| 2026-04-21 | 3.30x |
| 2026-04-20 | 3.41x |
| 2026-04-17 | 3.35x |
| 2026-04-16 | 3.41x |
| 2026-04-15 | 3.53x |
| 2026-04-14 | 3.42x |
| 2026-04-13 | 3.40x |
| 2026-04-10 | 3.20x |
| 2026-04-09 | 3.34x |
| 2026-04-08 | 3.21x |
| 2026-04-07 | 3.15x |
| 2026-04-06 | 3.35x |
| 2026-04-02 | 3.39x |
| 2026-04-01 | 3.49x |
| 2026-03-31 | 3.43x |
| 2026-03-30 | 3.05x |
| 2026-03-27 | 3.12x |
| 2026-03-26 | 3.20x |
| 2026-03-25 | 3.34x |
| 2026-03-24 | 3.22x |
| 2026-03-23 | 3.49x |
| 2026-03-20 | 3.35x |
| 2026-03-19 | 3.65x |
| 2026-03-18 | 3.59x |
| 2026-03-17 | 3.64x |
| 2026-03-16 | 3.52x |
| 2026-03-13 | 3.50x |
| 2026-03-12 | 2.04x |
| 2026-03-11 | 2.11x |
| 2026-03-10 | 2.24x |
| 2026-03-09 | 2.16x |
| 2026-03-06 | 2.23x |
| 2026-03-05 | 2.21x |
| 2026-03-04 | 2.31x |
| 2026-03-03 | 2.24x |
| 2026-03-02 | 2.36x |
| 2026-02-27 | 2.31x |
| 2026-02-26 | 2.31x |
| 2026-02-25 | 2.26x |
| 2026-02-24 | 2.27x |
| 2026-02-23 | 2.30x |
| 2026-02-20 | 2.44x |
| 2026-02-19 | 2.28x |
| 2026-02-18 | 2.30x |
| 2026-02-17 | 2.33x |
| 2026-02-13 | 2.40x |
| 2026-02-12 | 2.29x |
| 2026-02-11 | 2.43x |
| 2026-02-10 | 2.46x |
| 2026-02-09 | 2.44x |
| 2026-02-06 | 2.38x |
| 2026-02-05 | 2.42x |
| 2026-02-04 | 2.55x |
| 2026-02-03 | 2.66x |
| 2026-02-02 | 2.19x |
| 2026-01-30 | 2.35x |
| 2026-01-29 | 2.38x |
| 2026-01-28 | 2.50x |
| 2026-01-27 | 2.63x |
| 2026-01-26 | 2.46x |
| 2026-01-23 | 2.64x |
| 2026-01-22 | 2.64x |
| 2026-01-21 | 2.65x |
| 2026-01-20 | 2.64x |
| 2026-01-16 | 2.54x |
| 2026-01-15 | 2.54x |
| 2026-01-14 | 2.41x |
| 2026-01-13 | 2.36x |
| 2026-01-12 | 2.32x |
| 2026-01-09 | 2.28x |
| 2026-01-08 | 2.47x |
| 2026-01-07 | 1.92x |
| 2026-01-06 | 2.01x |
| 2026-01-05 | 2.11x |
| 2026-01-02 | 2.06x |
| 2025-12-31 | 2.06x |
| 2025-12-30 | 2.07x |
| 2025-12-29 | 2.13x |
| 2025-12-26 | 2.06x |
| 2025-12-24 | 1.97x |
| 2025-12-23 | 1.91x |
| 2025-12-22 | 1.84x |
| 2025-12-19 | 1.66x |
| 2025-12-18 | 1.54x |
| 2025-12-17 | 1.55x |
| 2025-12-16 | 1.54x |
| 2025-12-15 | 1.50x |
| 2025-12-12 | 1.54x |
| 2025-12-11 | 1.60x |
| 2025-12-10 | 1.56x |
| 2025-12-09 | 1.42x |
| 2025-12-08 | 1.44x |
| 2025-12-05 | 1.55x |
| 2025-12-04 | 1.38x |
| 2025-12-03 | 1.42x |
| 2025-12-02 | 1.37x |
| 2025-12-01 | 1.42x |
| 2025-11-28 | 1.52x |
| 2025-11-26 | 1.53x |
| 2025-11-25 | 1.49x |
| 2025-11-24 | 1.52x |
| 2025-11-21 | 1.52x |
| 2025-11-20 | 1.52x |
| 2025-11-19 | 1.52x |
| 2025-11-18 | 1.58x |
| 2025-11-17 | 1.68x |
| 2025-11-14 | 1.66x |
| 2025-11-13 | 1.57x |
| 2025-11-12 | 1.68x |
| 2025-11-11 | 1.65x |
| 2025-11-10 | 1.53x |
| 2025-11-07 | 1.22x |
| 2025-11-06 | 1.27x |
| 2025-11-05 | 1.31x |
| 2025-11-04 | 7.46x |
| 2025-11-03 | 8.43x |
| 2025-10-31 | 7.60x |
| 2025-10-30 | 7.28x |
| 2025-10-29 | 7.44x |
| 2025-10-28 | 7.70x |
| 2025-10-27 | 7.58x |
| 2025-10-24 | 7.49x |
| 2025-10-23 | 7.81x |
| 2025-10-22 | 7.52x |
| 2025-10-21 | 7.52x |
| 2025-10-20 | 8.11x |
| 2025-10-17 | 7.96x |
| 2025-10-16 | 8.10x |
| 2025-10-15 | 8.16x |
| 2025-10-14 | 8.10x |
| 2025-10-13 | 8.37x |
| 2025-10-10 | 8.40x |
| 2025-10-09 | 8.58x |
| 2025-10-08 | 8.51x |
| 2025-10-07 | 8.33x |
| 2025-10-06 | 8.27x |
| 2025-10-03 | 8.07x |
| 2025-10-02 | 8.30x |
| 2025-10-01 | 8.40x |
| 2025-09-30 | 8.14x |
| 2025-09-29 | 7.92x |
| 2025-09-26 | 7.90x |
| 2025-09-25 | 7.93x |
| 2025-09-24 | 7.67x |
| 2025-09-23 | 7.78x |
Showing the most recent 260 of 627 data points. The chart above shows the full history.
